Correction to: Digital messaging to support control for type 2 diabetes (StAR2D): a multicentre randomised controlled trial
BMC Public Health
.
2022 Apr 13;22(1):710.
doi: 10.1186/s12889-022-13085-0.
Authors
A Farmer
#
1
,
K Bobrow
#
2
,
N Leon
3
,
N Williams
4
,
E Phiri
5
,
H Namadingo
5
,
S Cooper
6
,
J Prince
7
,
A Crampin
5
,
D Besada
3
,
E Daviaud
3
,
L-M Yu
4
,
J N'goma
8
,
D Springer
9
,
B Pauly
10
,
L Tarassenko
7
,
S Norris
11
,
M Nyirenda
5
,
N Levitt
2
Affiliations
1
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
[email protected]
.
2
Chronic Disease Initiative for Africa, University of Cape Town, Cape Town, South Africa.
3
Health Systems Research Unit, South-African Medical Research Council, Cape Town, South Africa.
4
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
5
Malawi Epidemiology and Intervention Research Unit, Lilongwe, Malawi.
6
Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
7
Institute of Biomedical Engineering, Oxford, UK.
8
Kamuzu Central Hospital, Lilongwe, Malawi.
9
Boston Consulting Group, London, UK.
10
Department of Diabetes and Endocrinology, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.
11
Human Nutrition Unit, South African Medical Research Council, Johannesberg, South Africa.
#
Contributed equally.
PMID:
35413890
PMCID:
PMC9006479
DOI:
10.1186/s12889-022-13085-0
No abstract available
Publication types
Published Erratum
Grants and funding
MR/M016498/1/MRC_/Medical Research Council/United Kingdom